Back

Targeting phenotypic plasticity prevents metastasis and the development of chemotherapy-resistant disease

2022-03-21 oncology Title + abstract only
View on medRxiv
Show abstract

Cancer cells invoke phenotypic plasticity programs to drive disease progression and evade chemotherapeutic insults, yet until now there have been no validated clinical therapies targeting this process. Here, we identify a phenotypic plasticity signature associated with poor survival in basal/triple-negative breast cancer, in which androgen signalling is prominent. We establish that anti-androgen therapies block cancer stem cell function and prevent chemotherapy-induced emergence of new cancer st...

Predicted journal destinations